Tag: European Medicines Agency

AR101

Peanut OIT Phase 3 Trial Results Show Therapy Effective for Ages...

Aimmune plans to submit a Biologics License Application for AR101 to the FDA by the end of 2018.

Connect with Us

39,149FansLike
770FollowersFollow
2,714FollowersFollow
5,531FollowersFollow
40SubscribersSubscribe